| Characteristics | S. mutans <103 CFU/mL | S. mutans ≥103 CFU/mL | p-Value |
|---|---|---|---|
| 0 month | (n = 18) | (n = 39) | |
| Age (yr; mean ± SD) | 60.8 ± 18.1 | 69.2 ± 12.7 | 0.0478 |
| Sex (M/F) | 12/6 | 29/10 | 0.5563 |
| Height (cm; mean ± SD) | 165.1 ± 12.2 | 163.6 ± 7.9 | 0.5907 |
| Body weight (kg; mean ± SD) | 63.7 ± 17.9 | 63.9 ± 15.7 | 0.9628 |
| BMI (kg/m2; mean ± SD) | 23.0 ± 4.1 | 23.7 ± 4.9 | 0.5871 |
| Systolic blood pressure (mmHg; mean ± SD) | 127.7 ± 15.4 | 136.7 ± 19.2 | 0.0843 |
| Diastolic blood pressure (mmHg; mean ± SD) | 75.0 ± 10.7 | 76.7 ± 13.8 | 0.6431 |
| Hemoglobin (g/dL; mean ± SD) | 13.0 ± 2.6 | 11.5 ± 1.8 | 0.0151 |
| Serum albumin (g/dL; mean ± SD) | 4.0 ± 0.5 | 3.7 ± 0.3 | 0.032 |
| Serum creatinine (mg/dL; mean ± SD) | 2.0 ± 1.4 | 2.3 ± 1.2 | 0.3303 |
| eGFR (mL/min/1.73 m2; mean ± SD) | 38.1 ± 21.3 | 29.6 ± 20.8 | 0.1619 |
| Urinary protein (g/gCr; mean ± SD) | 1.0 ± 0.8 | 1.9 ± 2.1 | 0.1170 |
| % Urinary protein ≥2+ | 33.3 | 66.7 | 0.018 |
| Percentage of urinary sediment ≥5 RBC/HPF | 0 | 23.1 | 0.0263 |
| RAS-I medication rate, % | 66.7 | 59.0 | 0.5872 |
| 6 months later | (n = 18) | (n = 38) | |
| Number of S. mutans (log) | 0.5 ± 0.8 | 4.4 ± 1.5 | <0.0001 |
| eGFR (mL/min/1.73 m2; mean ± SD) | 38.9 ± 21.1 | 29.0 ± 20.6 | 0.1011 |
| Urinary protein (g/gCr; mean ± SD) | 1.0 ± 0.6 | 2.3 ± 2.2 | 0.0134 |
| % Urinary protein ≥2+ | 38.9 | 46.8 | 0.0388 |
| Percentage of urinary sediment ≥5 RBC/HPF | 11.1 | 23.7 | 0.277 |
| 12 months later | (n = 18) | (n = 33) | |
| Number of S. mutans (log) | 0.2 ± 0.7 | 4.1 ± 1.6 | <0.0001 |
| eGFR (mL/min/1.73 m2; mean ± SD) | 36.8 ± 21.4 | 27.5 ± 20.6 | 0.1251 |
| Urinary protein (g/gCr; mean ± SD) | 0.8 ± 0.7 | 1.7 ± 1.7 | 0.0162 |
| % Urinary protein ≥2+ | 27.8 | 67.6 | 0.0048 |
| Percentage of urinary sediment ≥5 RBC/HPF | 11.1 | 16.2 | 0.6221 |
| Variables | Odds ratio (95% confidence interval) | p-Value |
|---|---|---|
| Age | 1.010 (0.955-1.067) | 0.7323 |
| Sex | 3.949 (0.821-18.994) | 0.0865 |
| Systolic blood pressure (mmHg) | 1.047 (1.003-1.093) | 0.0346 |
| eGFR (mL/min/1.73 m2) | 0.985 (0.948-1.024) | 0.4519 |
| Hemoglobin (g/dL) | 1.246 (0.823-1.885) | 0.2982 |
| RAS-I medication | 1.852 (0.452-7.578) | 0.3915 |
| S. mutans ≥103 CFU/mL | 4.679 (1.008-21.732) | 0.0489 |
| Variables | Odds ratio (95% confidence interval) | p-Value |
|---|---|---|
| Age | 0.934 (0.799-1.091) | 0.3873 |
| Sex | 1.442 (0.050-42.000) | 0.8314 |
| BMI (kg/m2) | 0.723 (0.427-1.226) | 0.2292 |
| Systolic blood pressure (mmHg) | 1.031 (0.877-1.213) | 0.7092 |
| eGFR (mL/min/1.73 m2) | 1.097 (0.98-1.227) | 0.1076 |
| Proteinuria (g/gCr) (month 0) | 0.028 (0.001-1.414) | 0.0740 |
| RAS-I medication | 9.834 (0.082-1179.978) | 0.3493 |
| Degree of decrease in the number of S. mutans after 12 months | 0.022 (0.001-0.945) | 0.0466 |
| Characteristics | S. mutans <103 CFU/mL at month 0 (n = 18) |
P-value | S. mutans ≥103 CFU/mL at 12 months (n = 27) |
P-value | S. mutans <103 CFU/mL at 12 months (n = 6) |
|---|---|---|---|---|---|
| Chronic kidney disease subtypes | |||||
| Rate of IgA nephropathy, % | 27.8 | 0.7555 | 7.4 | 0.1334 | 33.3 |
| Rate of chronic glomerulonephritis, % | 16.7 | 0.9999 | 18.5 | 0.9173 | 16.7 |
| Rate of nephrosclerosis, % | 33.3 | 0.4461 | 22.2 | 0.1874 | 50.0 |
| Rate of diabetic nephropathy, % | 22.2 | 0.3033 | 48.1 | 0.0227 | 0 |
| Month 0 | |||||
| Age (yr; mean ± SD) | 60.8 ± 18.1 | 0.8411 | 68.1 ± 11.8 | 0.3721 | 62.2 ± 14.5 |
| Sex (M/F) | 12/6 | 0.9999 | 19/8 | 0.8644 | 4/2 |
| Number of S. mutans (log) | 0.1 ± 0.2 | <0.0001 | 5.2 ± 0.9 | 0.0014 | 4.2 ± 0.8 |
| BMI (kg/m2; mean ± SD) | 23.0 ± 4.1 | 0.1952 | 23.6 ± 4.7 | 0.2825 | 25.9 ± 7.0 |
| Systolic blood pressure (mmHg; mean ± SD) | 165.1 ± 12.2 | 0.7015 | 127.7 ± 15.4 | 0.2365 | 136.7 ± 19.2 |
| Diastolic blood pressure (mmHg; mean ± SD) | 75.0 ± 10.7 | 0.9343 | 77.8 ± 14.0 | 0.6949 | 75.5 ± 13.0 |
| Hemoglobin (g/dL; mean ± SD) | 13.0 ± 2.6 | 0.3044 | 11.8 ± 1.7 | 0.7991 | 12.0 ± 1.9 |
| Serum albumin (g/dL; mean ± SD) | 4.0 ± 0.5 | 0.3623 | 3.7 ± 0.4 | 0.6964 | 3.8 ± 0.3 |
| Serum creatinine (mg/dL; mean ± SD) | 2.0 ± 1.4 | 0.9008 | 2.2 ± 1.1 | 0.5669 | 1.9 ± 1.1 |
| eGFR (mL/min/1.73 m2; mean ± SD) | 38.1 ± 21.3 | 0.8802 | 30.8 ± 22.6 | 0.5632 | 36.5 ± 18.9 |
| Urinary protein (g/gCr; mean ± SD) | 1.0 ± 0.8 | 0.6453 | 2.0 ± 2.4 | 0.5299 | 1.5 ± 1.2 |
| Rate of proteinuria <0.3 g/gCr (%) | 5.6 | 0.5572 | 3.7 | 0.6824 | 0 |
| Percentage of urinary sediment ≥5 RBC/HPF | 0 | 0.0017 | 14.8 | 0.0185 | 50.0 |
| RAS-I medication rate, % | 66.7 | 0.4736 | 55.6 | 0.2147 | 83.3 |
| Month 12 | |||||
| Number of S. mutans (log) | 0.2 ± 0.7 | 0.0002 | 4.6 ± 1.2 | <0.0001 | 2.0 ± 1.0 |
| eGFR (mL/min/1.73 m2; mean ± SD) | 36.8 ± 21.4 | 0.6688 | 28.6 ± 21.9 | 0.6898 | 32.5 ± 17.8 |
| Urinary protein (g/gCr; mean ± SD) | 0.8 ± 0.7 | 0.9268 | 1.6 ± 1.5 | 0.1988 | 0.8 ± 1.0 |
| Rate of proteinuria <0.3 g/gCr (%) | 5.6 | 0.0028 | 7.4 | 0.0028 | 50.0 |
| Percentage of urinary sediment ≥5 RBC/HPF | 11.1 | 0.7525 | 18.5 | 0.9129 | 16.7 |